GlassScriptPhysician profile
Rick K Wilson
NPI 1598715567
$1,944.05
in general payments reported to CMS, 2019-2025
13 companies · $110 in 2025
The $110 reported for 2025 was less than what a typical Procedural Dermatology provider received nationally (typical 2025 total: $599).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242 · 2020: $302 · 2021: $222 · 2022: $256 · 2023: $426 · 2024: $386 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $922.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $921.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almirall LLC | $610.39 | 2019-2025 | Klisyri, Seysara |
| Galderma Laboratories, L.P. | $472.73 | 2019-2025 | Dysport |
| Sebela Pharmaceuticals INC. | $277.68 | 2019-2023 | Naftin |
| Abbvie INC. | $198.12 | 2023-2025 | Botox |
| Allergan, INC. | $106.93 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $78.68 | 2021-2023 | Absorica Ld, Winlevi |
| Leo Pharma INC. | $74.69 | 2019-2020 | |
| Pfizer INC. | $30.14 | 2022-2023 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $27.18 | 2020-2021 | |
| Amgen INC. | $23.15 | 2022 | |
| Sandoz INC. | $21.43 | 2019 | |
| Icad, INC | $12.10 | 2021 | |
| Sensus Healthcare, INC. | $10.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rick Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.